Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Oxford Nanopore Technologies PLC ( (GB:ONT) ) just unveiled an update.
Oxford Nanopore Technologies has reported a routine share transaction involving its chief financial officer, Nick Keher, under the company’s Share Incentive Plan. The plan allows employees to buy partnership shares out of gross salary, with the company providing matching shares on a one-for-one basis through newly issued ordinary shares.
On 12 March 2026, Keher acquired 121 partnership shares at £1.24 each, funded from his salary, and received a further 121 matching shares issued by the company at nil cost, all held by the plan trustee. The transaction, conducted on the London Stock Exchange, is disclosed in line with UK Market Abuse Regulation requirements and underlines ongoing alignment of senior management interests with those of shareholders through equity participation.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £1.70 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Spark’s Take on GB:ONT Stock
According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.
The score is held back primarily by weak financial performance—large ongoing losses and continued cash burn—despite improving revenue growth and solid gross margins. Technicals also detract due to a clear downtrend (below major moving averages and negative MACD). Offsetting factors include constructive earnings-call guidance with margin/OpEx discipline and a credible longer-term breakeven timeline, plus a relatively low-leverage balance sheet.
To see Spark’s full report on GB:ONT stock, click here.
More about Oxford Nanopore Technologies PLC
Oxford Nanopore Technologies plc is a UK-based life sciences company that develops and commercialises nanopore-based DNA and RNA sequencing technologies. Its products are used in research, clinical, and applied markets, offering real-time, scalable sequencing platforms to academic, healthcare, and industrial customers worldwide.
Average Trading Volume: 1,680,302
Technical Sentiment Signal: Strong Sell
Current Market Cap: £1.17B
See more insights into ONT stock on TipRanks’ Stock Analysis page.